Pure Global

HbA1c liquidirect HumaStar 600 - India CDSCO Medical Device Registration

HbA1c liquidirect HumaStar 600 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000206_e5be32071055bb14c95b2353480b77c2_472badab56619f33a2bea107e4637461. The license holder is Stedman Pharmaceuticals Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HbA1c liquidirect HumaStar 600
UID: IMP/IVD/2019/000206_e5be32071055bb14c95b2353480b77c2_472badab56619f33a2bea107e4637461

Device Class

Class B

Approving Authority

CDSCO

Product Information

Immunoassay for the direct photometric determination of HbA1c in human venous blood with EDTA on HumaStar 300 SR and HumaStar 600

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing